An international team of researchers, led by scientists at The Institute of Cancer Research, London, are planning to trial a novel saliva-based DNA test produced to predict men at risk of developing prostate cancer. The move follows findings of a study involving more than 140,000 men that identified 63 new genetic variations in the DNA
UK government has announced a new project to develop the world’s first fully-automated drug discovery facility with the aim to accelerate the production of new medicines and “transform” the pharma industry. Business Secretary, Greg Clark, stated that the venture, which is based at the government-funded research facility the Rosalind Franklin Institute in Harwell, Oxfordshire, will
Developing medicines to treat pulmonary fibrosis, one of the most common and life threatening forms of lung disease, is notoriously difficult. It is challenging to mimic how the disease damages and scars lung tissue over time, which often causes scientists to employ a hodgepodge of time-consuming and costly techniques to assess the effectiveness of potential
